NEUROSIGMA
NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.
NEUROSIGMA
Social Links:
Industry:
Biotechnology Developer Platform Medical
Founded:
2008-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.neurosigma.com
Total Employee:
11+
Status:
Active
Contact:
3104793114
Email Addresses:
[email protected]
Total Funding:
18.36 M USD
Technology used in webpage:
SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Nginx Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Investors List
KT Corp
KT Corp investment in Corporate Round - NeuroSigma
Official Site Inspections
http://www.neurosigma.com
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeuroSigma"
NeuroSigma
Oct 17, 2022 · The Monarch eTNS System is indicated for the treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD) as a monotherapy in patients ages 7 through 12 years old who are not currently taking prescription …See details»
NeuroSigma
NeuroSigma's leadership is made up of experts in business management and the healthcare industry. Together they provide extensive experience gained through years of creating and guiding successful companies and innovative medical …See details»
NeuroSigma - Crunchbase Company Profile & Funding
NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments …See details»
NeuroSigma - LinkedIn
The future of neurological disorder treatment. | NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology.See details»
NeuroSigma Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for NeuroSigma. Use the PitchBook Platform to explore the full profile. Request a free trial Log inSee details»
NeuroSigma Company Profile - Office Locations, Competitors
NeuroSigma is a life sciences company developing bioelectronic technologies. It offers TNS neuromodulation therapies for a variety of neurological and neuropsychiatric disorders.See details»
NeuroSigma Announces FDA Clearance of Monarch …
LOS ANGELES, April 23, 2019 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles -based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating...See details»
NeuroSigma Receives Health Canada Approval for Its Monarch
LOS ANGELES, May 2, 2013 /CNW/ - NeuroSigma, Inc., a California-based medical device company, today announced that it has received a Class 2 medical device license for its …See details»
NeuroSigma Announces Commercial Launch of The …
Oct 17, 2022 · NeuroSigma is a Los Angeles, California-based bioelectronic medical device company developing technologies to transform medical practice and patients' lives. The company is commercializing the...See details»
NeuroSigma Announces King’s College London Team Receives …
Apr 7, 2022 · Double-blind randomized controlled trial of eTNS for pediatric ADHD will enroll up to 150 participants at two sites in London and Southampton. NeuroSigma’s Monarch eTNS …See details»
NeuroSigma gets green light from FDA for ADHD wearable
Jan 18, 2024 · NeuroSigma has received US Food and Drug Administration (FDA) approval for its second-generation Monarch external trigeminal nerve stimulation (eTNS) system to treat …See details»
NeuroSigma Announces that Enrollment Commences in Two …
LOS ANGELES, Nov. 08, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) …See details»
Research Overview - NeuroSigma
NeuroSigma is researching trigeminal nerve stimulation (TNS) as a novel neuromodulation therapy for a variety of neurological and neuropsychiatric disorders. TNS was invented at the …See details»
NeuroSigma Announces Publication of ADHD Clinical Trial Data …
Oct 22, 2020 · NeuroSigma is focused on TNS bioelectronics therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), …See details»
KT and NeuroSigma Announce Strategic Digital Health Partnership
Jun 14, 2021 · NeuroSigma is the developer of the Monarch eTNS System ®, which uses non-invasive external trigeminal nerve stimulation (eTNS) to treat neurological and …See details»
NeuroSigma - Overview, News & Similar companies | ZoomInfo.com
NeuroSigma contact info: Phone number: (310) 479-3100 Website: www.neurosigma.com What does NeuroSigma do? NeuroSigma is a California-based life sciences company established to …See details»
Press Releases - NeuroSigma
Jan 31, 2023 · June 14, 2022 » NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD. April 7, 2022 …See details»
NeuroSigma Continues to Build a Substantial Global Bioelectronics ...
Mar 12, 2021 · NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives.See details»
NeuroSigma Receives FDA Breakthrough Device Designation for
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its …See details»